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Wednesday, March 9, 2011 549aWe rationally designed, synthesized and tested a novel set of ligands to ex-
ploit a hydrophobic cavity in the vicinity of the docking pose of known li-
gands. All novel ligands showed improved, affinities with respect to their
reference compounds, in good quantitative agreement between experiment
and simulation, some of them reaching nanomolar affinities. Studying a series
of site-specific mutations, we could computationally rationalize the receptor
selectivity of specific compounds to either preferentially bind CB1 or CB2,
respectively.
[1] S.H. Burstein and R.B. Zurier (2009) Cannabinoids, Endocannabinoids, and
Related Analogs in Inflammation,
AAPS J. 11(1), 109-119.
[2] H. Merlitz, B. Burghardt andW. Wenzel (2003) Application of the Stochas-
tic Tunneling Method to High Throughput Database Screening,
Chem. Phys. Lett. 370, 68-73.
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Field-Modulated Magnetic Birefringence Relaxation to Assay b-Adrener-
gic Receptor-Ligand Association
Louis H. Strong, Daniel B. Hall, Hiep-hoa Nguyen, Gyula Varadi.
We developed a platform for monitoring the association between biologically
active molecules and their cognate receptors based on measuring rate changes
of magnetic birefringence relaxation of superparamagnetic nanoparticles. The
method is particularly designed for rapid screening of display libraries and
mutant receptor libraries expressed in bacteria and yeast. The magnitude of
birefringence rate change after particle orientation in a magnetic field reflects
the difference of nanoparticle hydrodynamic volume upon formation of the
‘‘receptor-ligand complex’’. The rationale for using nanoparticle birefrin-
gence to identify ligand and receptor interactions is that it eliminates the
need for removing unbound ligands. We have previously demonstrated that
maghemite nanoparticles, decorated with ligand molecules, exhibit longer re-
laxation times when associated with proteins, viruses and small size microor-
ganisms. We utilize magnetic field-modulated birefringence to monitor
association between a ligand (alprenolol) immobilized on the surface of mag-
netic nanoparticles and b-adrenergic receptor overexpressed on the cell sur-
face of bacteria and yeast. Upon association of the ligand with the
receptor, we observed an increase in the birefringence rate constant, an effect
that was fully reversible by adding b-adrenergic competitor ligands. Rate con-
stant distributions were reconstructed using the Phase Function Method. We
show that birefringence signals can be used to monitor the dynamics of par-
ticle rotational alignment as well as rotational relaxation. Alignment dynam-
ics are characteristic of the number of accessible receptor sites while
relaxation characterizes the aggregate size. This novel approach is applicable
in systems where the interaction of ligand with cognate receptor does not ac-
tivate intracellular pathways and thus are difficult to monitor with a ratio-
fluorometric platform. This method will be useful for a broad range of
applications, including discovery research to develop small molecule drugs
and for identification of orphan receptors and biologically active peptides
and proteins from display libraries.
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Transient Kinetics of Nucleotide Binding to the P-glycoprotein Multidrug
Transporter
Miguel R. Lugo, Joseph W.K. Chu, Frances J. Sharom.
The P-glycoprotein multidrug transporter (Pgp) is a member of the ABC
(ATP-binding cassette) superfamily of proteins, and contains two highly con-
served cytosolic nucleotide-binding domains (NBDs). These domains couple
ATP hydrolysis to the export of a variety of hydrophobic natural products,
chemotherapeutic drugs and peptides. Pgp ATPase activity has been exten-
sively characterized, but many details of the catalytic cycle of ATP hydro-
lysis remain unexplored. The fluorescent nucleotide analogue, TNP-ADP,
interacts with the NBDs of Pgp, and the stoichiometry and affinity of binding
were previously determined in our laboratory. Transient kinetic methods are
commonly used to investigate the mechanism of molecular processes over
a time-scale from milliseconds to hundreds of seconds. In this work, we
studied the binding of TNP-ADP to Pgp using rapid stopped-flow kinetics.
In these experiments, the binding reaction was monitored by following dif-
ferent fluorescent signals, under pseudo-first-order conditions (excess ligand).
The time course of TNP-ADP binding displayed five relaxation times (ti’s)
over a time-span of 300 sec, which correspond to at least five different tran-
sitions. All the relaxation times presented a strong temperature-dependence.
The time course of the reaction was analyzed by the computational tool
Global Kinetic Explorer (KinTek, USA), using several models of sequential
isomerizations after/before the fast bimolecular binding reaction. Also, theparameters were analyzed using the matrix projection operator technique
for kinetic data (Bujalowski et al., 2000, J. Mol. Biol. 295:831). Both ap-
proaches provide, for the first time, information about the rate constants
and fluorescent properties of the diverse intermediates formed during binding
of TNP-ADP to Pgp. Elucidation of the details of the interaction of nucleo-
tides with Pgp is of prime importance for formulation of a detailed mecha-
nism of action of the transporter.
This research is supported by a grant from the Canadian Cancer Society.
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Identification of an Efficacy Pharmacophore for m Opioid Receptor Li-
gands Using the Conformationally Sampled Pharmacophore (CSP)
Method
Jihyun Shim, Andrew Coop, Alexander D. MacKerell Jr.
m opioid receptor agonists and antagonists play a critical role in the treatment
of severe pain and as treatments for drug abuse. Their structure activity rela-
tionships (SAR) have been extensively investigated followed by lead optimi-
zation. However, challenges remain in improving the utility of m ligands with
respect to reducing adverse effects such as tolerance, dependence, constipa-
tion, etc. while maintaining the potency of current medicines. To facilitate
the meeting of these challenges, consensus pharmacophore models for diverse
classes of m opioid receptor ligands were established and we constructed pre-
dictive model differentiating agonists and antagonists activities using the con-
formationally sampled pharmacophore (CSP) method. The predictability of
the models was validated against a number of classes of opioids including
4,5-Epoxymorphinans, Diels-Alder adducts of thebaine, Benzomorphans,
Methadone, Fentanyl, and, notably, non-nitrogenous opioids; a collection of
compounds which have eluded a consensus SAR of opioids for decades.
The consensus model was derived by virtue of CSP method incorporating
flexibility of molecules through using all-accessible conformers in model de-
velopment and by eliminating any limitations associated with alignment pro-
cedures. The procedures to develop and features of the CSP model will be
presented.
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Probing Binding of Apelin to the Extracellular Loops of the Apelin Recep-
tor (APJ) in Lipid Mimetic Environments
Pascaline Ngweniform, Jan K. Rainey.
a Department of Biochemistry & Molecular Biology and b Department of
Chemistry, Dalhousie University, Halifax, NS B3H 1X5.
The apelin receptor, previously called APJ, is a G protein-coupled receptor
highly expressed in the central nervous system (CNS), cardiovascular system,
the adipoinsular axis and the mammary glands, among other tissues and organ
systems. The apelinergic system plays important biological functions in the
regulation of blood pressure, blood glucose, drinking behavior and food intake.
The action of this system is also implicated in tumour angiogenesis, diabetes
and cardiovascular diseases. In addition, the apelin receptor is a co-receptor
for human immunodeficiency virus type 1 (HIV1) and simian immunodefi-
ciency virus (SIV). Despite these roles, the mechanism of activation of apelin
receptor by its cognate ligand has not been studied at the molecular level. Fol-
lowing the ‘‘divide and conquer’’ approach for membrane protein characteriza-
tion, we present the biophysical characterization of the interaction of two
extracellular loops of the apelin receptor (extracellular loops 1, EL1 and 3,
EL3) with a fluorescently-tagged apelin analogue in lipid environment. Pep-
tides were synthesized by solid phase peptide synthesis and purified by high-
performance liquid chromatography. Characterization both of the peptides in
isolation and of the binding between apelin and EL peptides is provided using
circular dichroism spectroscopy, fluorescence resonance energy transfer and
nuclear magnetic resonance spectroscopy. These results provide insight into
understanding of the apelinergic system at the molecular level and provide
the first structural information on the apelin receptor for the development of
therapeutics targeting this system.
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Design and Biophysical Characterization of a Single Chain Four-alpha-
helix Bundle Protein Which Binds Volatile General Anesthetics
Lucia M. Morstadt, Qing Cheng Meng, Jonas S. Johansson.
In order to investigate the interaction of volatile general anesthetics with their
putative membrane protein targets, we designed a four-alpha-helix bundle
protein in a single protein chain. The four alpha helices, connected by three
8 glycine loops, had the sequence A, B, B’, A’. The DNA sequence was de-
signed with the goal of making helices with the same amino acid sequence
(helix A and A’, B and B’, respectively) as different as possible in their
